{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:36:58Z","timestamp":1786981018519,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10689-020-00179-0","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T22:07:46Z","timestamp":1587679666000},"page":"291-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Primary fallopian tube carcinoma (PFTC) in a BRIP-1 mutation carrier: the first case report"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3567-3278","authenticated-orcid":false,"given":"Giovanni","family":"Grandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Caroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Alboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cortesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Toss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Botticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Facchinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"issue":"3","key":"179_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1006\/gyno.1998.5267","volume":"72","author":"I Alvarado-Cabrero","year":"1999","unstructured":"Alvarado-Cabrero I, Young RH, Vamvakas EC, Scully RE (1999) Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors. Gynecol Oncol 72(3):367\u2013379","journal-title":"Gynecol Oncol"},{"issue":"3","key":"179_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ygyno.2014.04.013","volume":"133","author":"DG Mutch","year":"2014","unstructured":"Mutch DG, Prat J (2014) 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer. Gynecol Oncol 133(3):401\u2013404","journal-title":"Gynecol Oncol"},{"issue":"5","key":"179_CR3","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A et al (2003) Average risks of breast cancer and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130","journal-title":"Am J Hum Genet"},{"issue":"17","key":"179_CR4","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1093\/hmg\/ddu172","volume":"23","author":"H Song","year":"2014","unstructured":"Song H et al (2014) The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population. Hum Mol Genet 23(17):4703\u20134809","journal-title":"Hum Mol Genet"},{"key":"179_CR5","first-page":"341723","volume":"015","author":"A Toss","year":"2015","unstructured":"Toss A et al (2015) Hereditary ovarian cancer: not only BRCA 1 and 2 genes. Biomed Res Int 015:341723","journal-title":"Biomed Res Int"},{"issue":"11","key":"179_CR6","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/ng.955","volume":"43","author":"T Rafnar","year":"2011","unstructured":"Rafnar T et al (2011) Mutations in BRIP1 confer high risk of ovarian cancer. Nat Genet 43(11):1104\u20131107","journal-title":"Nat Genet"},{"issue":"11","key":"179_CR7","doi-asserted-by":"publisher","first-page":"djv214","DOI":"10.1093\/jnci\/djv214","volume":"107","author":"SJ Ramus","year":"2015","unstructured":"Ramus SJ et al (2015) Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer. J Natl Cancer Inst 107(11):djv214","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"179_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13058-018-0935-9","volume":"20","author":"N Weber-Lassalle","year":"2018","unstructured":"Weber-Lassalle N et al (2018) BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer. Breast Cancer Res 20(1):7","journal-title":"Breast Cancer Res"},{"issue":"4","key":"179_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.23736\/S0026-4806.19.06091-9","volume":"110","author":"A Toss","year":"2019","unstructured":"Toss A et al (2019) Hereditary ovarian cancers: state of the art. Minerva Med 110(4):301\u2013319","journal-title":"Minerva Med"},{"key":"179_CR10","unstructured":"National Comprehensive Cancer Network (2020) NCCN Clinical Practice guidelines in oncology. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic. Version 1. 2020 \u2013 December 4, 2019. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf . Accessed 15 Apr 2020"},{"issue":"1","key":"179_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/his.12046","volume":"62","author":"R Vang","year":"2013","unstructured":"Vang R, Shih IM, Kurman RJ (2013) Fallopian tube precursors of ovarian low- and high-grade serous neoplasms. Histopathology 62(1):44\u201358","journal-title":"Histopathology"},{"issue":"1","key":"179_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","volume":"100","author":"A Finch","year":"2006","unstructured":"Finch A, Shaw P, Rosen B, Murphy J, Narod SA, Colgan TJ (2006) Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol 100(1):58\u201364","journal-title":"Gynecol Oncol"},{"issue":"11","key":"179_CR13","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/ng1902","volume":"38","author":"S Seal","year":"2006","unstructured":"Seal S et al (2006) Truncating mutations in the Fanconi anaemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38(11):1239\u20131241","journal-title":"Nat Genet"},{"issue":"5","key":"179_CR14","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ajog.2017.04.011","volume":"217","author":"KL Ring","year":"2017","unstructured":"Ring KL, Garcia C, Thomas MH, Modesitt SC (2017) Current and future role of genetic screening in gynecologic malignancies. Am J Obstet Gynecol 217(5):512\u2013521","journal-title":"Am J Obstet Gynecol"},{"key":"179_CR15","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB et al (2017) Risk of breast, ovarian and controlateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402\u20132416","journal-title":"JAMA"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-020-00179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-020-00179-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-020-00179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T00:18:39Z","timestamp":1619309919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-020-00179-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["179"],"URL":"https:\/\/doi.org\/10.1007\/s10689-020-00179-0","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]},"assertion":[{"value":"5 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declares that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}